Form 8-K - Current report:
SEC Accession No. 0001279569-25-000673
Filing Date
2025-06-26
Accepted
2025-06-26 17:00:52
Documents
12
Period of Report
2025-06-20
Items
Item 1.03: Bankruptcy or Receivership
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 26900
  Complete submission text file 0001279569-25-000673.txt   189395

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20250620.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20250620_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20250620_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3470
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 251081160
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)